BD & Magnolia Medical Collab to Reduce Blood Culture Contamination
BD and Magnolia Medical Technologies aim to help hospitals reduce blood culture contamination and improve testing accuracy.
BD and Magnolia Medical Technologies aim to help hospitals reduce blood culture contamination and improve testing accuracy.
Thermo Fisher Scientific and Q-linea have launched the ASTar System—a rapid antimicrobial susceptibility testing system that delivers results in 6 hours.
BD has announced the US launch of a urine culture application for use with the BD Kiestra lab automation incubation and imaging system.
The contract covers the T2Dx instrument as well as the T2Bacteria and T2Candida panels, which detect sepsis-causing bacterial and fungal pathogens directly from whole blood.
The SureSelect XT HS2 RNA Reagent Kit features a modular design for a simple and parallel approach for both RNA and DNA samples with clinical NGS.
The kit combines the Steripath Gen2 initial specimen diversion device with additional supplies required for the collection of blood culture samples that are virtually free of contamination.
Rapid molecular diagnostics contribute to improved patient outcomes.